• EN

Table GPS-10. Frequency of use of cannabis amongst users in the last 30 days in national general population surveys.

Part (ii) All adults (aged 15 - 64) - 2007 field trial.

CountryYear of surveySample size (15–64)Last month prevalence (15–64 years old)(%)Number of users in last 30 days (15–64)1 to 3 days/30 (%)4 to 9 days/30 (%)10 to 19 days/30 (%)20+ days/30 (%) Prevalence of daily or almost daily use (20 days or more/30) 15–64 years old(%)Prevalence of daily or almost daily use (20 days or more/30) 15-34 years old(%)
Czech Republic200435264.817043.430.718.77.2 0.30.9
Denmark200589562.61875818.67.515.9 0.40.8
Germany200380613.43714715.514.123.4 0.81.8
Ireland2006/0749182.63728.310.324.4 0.61.1
Greece200447810.93962.16.718.912.3 0.10.2
Spain2005/06283248.7246031.822.614.731 2.74.5
France2005258794.8122235.716.715.232.4 1.63.3
Italy2005279955.8153447.624.510.217.6 11.5
Cyprus200635041.4476117.38.713 0.20.3
United Kingdom(1)2005/06299324.8::::::2.1


Those that declared having used cannabis in 20 days or more in the 30 days previous to the interview are referred to as 'daily or almost daily users' in the texts.

(1) For United Kingdom frequency collected as frequency in the last 12 months but analysis presented is based only on users in the last 30 days. Data refer to 16 to 24 years.

For methods and definitions on population surveys in general, see methods and definitions - prevalence and patterns of drug use in the general population.

See also 'General notes for interpreting data' on the Explanatory notes and help page.


See Table GPS-0.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 09 July 2012